Search Results - Maria Rubinacci

A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pex... Autoría: Jayesh Desai, Andrew J. Wagner, Irene Carrasco Garcia, Marilena Cesari, Michael Gordon, Chia‐Chi Lin, Zsuzsanna Papai, Christopher W. Ryan, William D. Tap, Jonathan C. Trent, Hans Gelderblom, Peter Grimison, Antonio López Pousa, Brian A. Van Tine, Maria Rubinacci, Dong Dai, Abdul Waheed Rajper, Kristen Tecson, Margaret Wooddell, Silvia Stacchiotti